Cancer genes induced by malathion and parathion in the presence of estrogen in breast cells.

The identification of genes involved in the process of neoplastic transformation is essential for analyzing the progression of breast cancer when induced by endogenous and exogenous agents, among which are the estrogens and the organophosphorous pesticides, respectively. It is important to consider the impact of such substances when they are present in combination. In vitro experimental models are needed in order to understand breast carcinogenesis. The aim of this work was to examine the effect of 17beta estradiol (estrogen) combined with either malathion or parathion on the transformation of human breast epithelial cells in vitro. Results showed that estrogen combined with either malathion or parathion altered cell proliferation and induced cell transformation as well as exhibited significant invasive capabilities as compared to the control MCF-10F cell line. Several genes were up-regulated by the effect of all of the treatments, such as the cyclins, cyclin D1 and cyclin-dependent kinase 4, IGFBP3 and IGFBP5, and keratin 18. The c-Ha-ras oncogene was up-regulated by the effect of malathion alone and with the combination of estrogen and either malathion or parathion. The DVL1 gene was up-regulated only with malathion alone and the combination of parathion with estrogen. Expression of the HSP 27, MCM2 and TP53 inducible protein 3 genes was up-regulated with malathion alone and with the combination of estrogen and either malathion or parathion while TP53 (Li-Fraumeni syndrome) was up-regulated by estrogen alone and malathion alone. Thus, we suggest that pesticides and estrogens affect human breast cells inducing molecular changes indicative of transformation.

[1]  G. Hannon,et al.  A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 , 1993, Nature.

[2]  E V Koonin,et al.  A common set of conserved motifs in a vast variety of putative nucleic acid-dependent ATPases including MCM proteins involved in the initiation of eukaryotic DNA replication. , 1993, Nucleic acids research.

[3]  N. Perrimon,et al.  Isolation and characterization of a mouse homolog of the Drosophila segment polarity gene dishevelled. , 1994, Developmental biology.

[4]  A. Giordano,et al.  Cyclins, cyclin-dependent kinases and cdk inhibitors: implications in cell cycle control and cancer. , 1995, Critical reviews in eukaryotic gene expression.

[5]  C. Sherr,et al.  Regulation of cyclin D-dependent kinase 4 (cdk4) by cdk4-activating kinase , 1994, Molecular and cellular biology.

[6]  M. Inagaki,et al.  Cell Cycle- and Chromatin Binding State-dependent Phosphorylation of Human MCM Heterohexameric Complexes , 1998, The Journal of Biological Chemistry.

[7]  T. Hei,et al.  Profiling of differentially expressed genes induced by high linear energy transfer radiation in breast epithelial cells , 2001, Molecular carcinogenesis.

[8]  A. Levine.  p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.

[9]  V. Mitev,et al.  [Insulin-like growth factors]. , 1990, Eksperimentalna meditsina i morfologiia.

[10]  D. Lane,et al.  Regulation of the specific DNA binding function of p53 , 1992, Cell.

[11]  C. Georgopoulos,et al.  Role of the major heat shock proteins as molecular chaperones. , 1993, Annual review of cell biology.

[12]  C. Georgopoulos,et al.  The universally conserved GroE (Hsp60) chaperonins. , 1991, Annual review of microbiology.

[13]  Michael Ashburner,et al.  Heat shock, from bacteria to man , 1982 .

[14]  G. Lorimer,et al.  Dynamics of the chaperonin ATPase cycle: implications for facilitated protein folding. , 1994, Science.

[15]  Z. Gucev,et al.  Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics. , 1996, The international journal of biochemistry & cell biology.

[16]  B. Olofsson,et al.  Expression of the ras-related ralA, rho12 and rab genes in adult mouse tissues. , 1988, Oncogene.

[17]  R. Dickson,et al.  Control of human breast cancer by estrogen, growth factors, and oncogenes. , 1988, Cancer treatment and research.

[18]  R. Baxter,et al.  Insulin-like growth factor binding proteins as glucoregulators. , 1995, Metabolism: clinical and experimental.

[19]  H. Höfler,et al.  Cytokeratin expression in simple epithelia. III. Detection of mRNAs encoding human cytokeratins nos. 8 and 18 in normal and tumor cells by hybridization with cDNA sequences in vitro and in situ. , 1986, Differentiation; research in biological diversity.

[20]  S. Nagalla,et al.  Synthesis and Characterization of Insulin-like Growth Factor-binding Protein (IGFBP)-7 , 1996, The Journal of Biological Chemistry.

[21]  J. Downing,et al.  PCTAIRE-1 and PCTAIRE-3, two members of a novel cdc2/CDC28-related protein kinase gene family. , 1992, Oncogene.

[22]  G. Colditz.  Epidemiology and Prevention of Breast Cancer , 2005, Cancer Epidemiology Biomarkers & Prevention.

[23]  K. Ohtsuka,et al.  Cloning of a cDNA for heat-shock protein hsp40, a human homologue of bacterial DnaJ. , 1993, Biochemical and biophysical research communications.

[24]  T. E. Shellenberger.  Bioassay of malathion for possible carcinogenicity. , 1978, National Cancer Institute carcinogenesis technical report series.

[25]  Wei-Min Liu,et al.  Analysis of high density expression microarrays with signed-rank call algorithms , 2002, Bioinform..

[26]  M. Binoux.  The IGF system in metabolism regulation. , 1995, Diabete & metabolisme.

[27]  R. Axel,et al.  A novel ras-related gene family , 1985, Cell.

[28]  M. Bucan,et al.  Structure and localization of the IGFBP‐1 gene and its expression during liver regeneration , 1994, Hepatology.

[29]  J. Godbold,et al.  Pesticides and polychlorinated biphenyl residues in human breast lipids and their relation to breast cancer. , 1992, Archives of environmental health.